year
Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 54-21-7 | ||
EC NO: | 200-198-0 | ||
Molecular Formula: | C7H5O3Na | ||
Molecular Weight: | 160.1 | ||
Specification: | BP/USP/EP/JP | ||
InChI: | InChI=1/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1 | ||
Packing: | Packing in fiberboard-made pail attached with paper or polyethylene bag inside. | ||
Product description: Appearance: Colorless crystal or crystal powder or crystal slice. Content: 99.0-101.0% Acidity: 20ml sample not more than 2.0ml of 0.01M NaOH Sulphate: ≤600PPm Heavy metal: ≤20PPm Chloridate: ≤200PPm Loss on drying: ≤0.5% Acidity: Can not exceed 2.0 ml when consuming 0.01MnaOH standard solution |
|||
Uses: | Fever-allaying,analgesia,antirheumatism,used for arthralgia and rheumatoid arthritis partially. | ||
Synonyms: | sodium salicylate usp;Salicylic acid sodium salt;salicylic acid sodium;Sodium Salicylate/Salicylic acid sodium salt;Sodium sallicylate;Salicylic acid, sodium saltSodium ;o-hydroxybenzoic sodium salt;2-Hydroxybenzoic acid sodium salt; | ||
Molecular Structure: |
![]() |